James Turkson
Impact in
- Oncology top 0.05%
- Cytokine Signaling Pathways and Interactions
- Toxicology top 0.1%
- Bioactive Compounds and Antitumor Agents
Papers in
- Oncology 74
- Cytokine Signaling Pathways and Interactions 69
-
- PI3K/AKT/mTOR signaling in cancer 29
- Protein Tyrosine Phosphatases 15
- Co-authors
- Richard Jove (36 shared papers)Tammy Bowman (5 shared papers)Roy Garcia (2 shared papers)Khandaker Siddiquee (7 shared papers)Peibin Yue (31 shared papers)Eric B. Haura (5 shared papers)Saı̈d M. Sebti (11 shared papers)Shumin Zhang (8 shared papers)
- Journals
- Oncogene (8 papers)Cancer Research (7 papers)Bioorganic & Medicinal Chemistry Letters (6 papers)Molecular Cancer Therapeutics (6 papers)Journal of Biological Chemistry (6 papers)
- Partner nations
- United StatesCanadaChina
In The Last Decade
James Turkson
106 papers receiving 15.3k citations
James Turkson's Hit Papers
Peers
Comparison fields: 5 of 133
- Oncology 8.8k
- Toxicology 615
- Pathology and Forensic Medicine 2.5k
- Cancer Research 2.1k
- Immunology 2.9k
Countries citing papers authored by James Turkson
This map shows the geographic impact of James Turkson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Turkson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Turkson more than expected).
Fields of papers citing papers by James Turkson
This network shows the impact of papers produced by James Turkson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Turkson. The network helps show where James Turkson may publish in the future.
Co-authors
The 25 scholars most cited alongside James Turkson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | STATs in oncogenesis Hit paper breakdown → | 2000 | 1531 |
| 2 | Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells Hit paper breakdown → | 1999 | 1409 |
| 3 | Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis Hit paper breakdown → | 2002 | 1019 |
| 4 | Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity Hit paper breakdown → | 2007 | 617 |
| 5 | Stat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell Transformation Hit paper breakdown → | 1998 | 583 |
| 6 | STAT proteins: novel molecular targets for cancer drug discovery Hit paper breakdown → | 2000 | 540 |
| 7 | Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression Hit paper breakdown → | 2001 | 504 |
| 8 | Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways Hit paper breakdown → | 2005 | 493 |
| 9 | Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. | 2003 | 484 |
| 10 | 2006 | 467 | |
| 11 | 2008 | 421 | |
| 12 | 2001 | 368 | |
| 13 | 2005 | 365 | |
| 14 | Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer Hit paper breakdown → | 2022 | 356 |
| 15 | 2013 | 352 | |
| 16 | 2008 | 343 | |
| 17 | 2003 | 315 | |
| 18 | 2012 | 288 | |
| 19 | 2012 | 270 | |
| 20 | 2000 | 259 |
About James Turkson
James Turkson is a scholar working on Oncology, Molecular Biology, Pathology and Forensic Medicine, Organic Chemistry and Pharmacology, having authored 109 papers that have together received 15.6k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (69 papers), PI3K/AKT/mTOR signaling in cancer (29 papers), Cancer Mechanisms and Therapy (19 papers), Protein Tyrosine Phosphatases (15 papers), Synthesis and biological activity (11 papers), Microbial Natural Products and Biosynthesis (11 papers), interferon and immune responses (6 papers) and Fungal Biology and Applications (6 papers). The work is most often cited by research in Oncology (8.8k citations), Toxicology (615 citations), Pathology and Forensic Medicine (2.5k citations), Cancer Research (2.1k citations) and Immunology (2.9k citations). James Turkson has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Richard Jove, Tammy Bowman, Roy Garcia, Khandaker Siddiquee, Peibin Yue, Eric B. Haura, Saı̈d M. Sebti, Shumin Zhang, James G. Karras and Robyn Catlett-Falcone. Their work appears in journals such as Oncogene, Cancer Research, Bioorganic & Medicinal Chemistry Letters, Molecular Cancer Therapeutics and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.